Clinical Trial Update: Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reporting completion of evaluation for a fixed-dose combination of glimepiride and metformin in Chinese adults with Type 2 Diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• glimepiride/metformin fixed-dose combination (glimepiride/metformin)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED